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Previous studies of the Sleeping Beauty (SB) transposon system, as an insertional mutagen in the germline of mice,
have used reverse genetic approaches. These studies have led to its proposed use for regional saturation mutagenesis
by taking a forward-genetic approach. Thus, we used the SB system to mutate a region of mouse Chromosome 11 in a
forward-genetic screen for recessive lethal and viable phenotypes. This work represents the first reported use of an
insertional mutagen in a phenotype-driven approach. The phenotype-driven approach was successful in both
recovering visible and behavioral mutants, including dominant limb and recessive behavioral phenotypes, and
allowing for the rapid identification of candidate gene disruptions. In addition, a high frequency of recessive lethal
mutations arose as a result of genomic rearrangements near the site of transposition, resulting from transposon
mobilization. The results suggest that the SB system could be used in a forward-genetic approach to recover
interesting phenotypes, but that local chromosomal rearrangements should be anticipated in conjunction with single-
copy, local transposon insertions in chromosomes. Additionally, these mice may serve as a model for chromosome
rearrangements caused by transposable elements during the evolution of vertebrate genomes.
Citation: Geurts AM, Collier LS, Geurts JL, Oseth LL, Bell ML, et al. (2006) Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization
from chromosomal concatemers. PLoS Genet 2(9): e156. DOI: 10.1371/journal.pgen.0020156
Introduction
The Sleeping Beauty (SB) transposable element is an effective
tool for generating mutations in the germline [1–5] and
somatic cells [6,7] of mice. Previous studies indicate that the
advantages of this cut-and-paste transposon system are four
fold. First, because the element is active in vivo, breeding
transgenic mice is all that is required to generate heritable
mutations. Second, insertional mutations in genes can be
identiﬁed and tracked through generations using simple
PCR-based techniques because the transposon vector serves
as a molecular tag. Third, SB transposons have a strong
tendency to reinsert during transposition at loci closely
linked to their donor site. It has been proposed that this
tendency will allow one to develop screens to saturate regions
of the mouse genome that are syntenous to human genomic
regions known to harbor disease genes [1,4]. A recent study
achieved germline saturation mutagenesis by mobilizing
chromosomally resident transposons in a region of mouse
Chromosome 12 [5]. A fourth advantage is that the trans-
poson vector can be designed to include functional elements
that report expression patterns of mutated genes [4,8].
Previous strategies for the use of SB for germline mutagenesis
have used reverse-genetic approaches, whereby potential
mutations have been selected based on sequence information
[1,8] or expression analysis [4,5]. The goal of the study
presented here, rather, was to test whether the SB transposon
system could be used as a mutagen for forward-genetic
studies in the mouse germline.
Gene-dense regions, which share a high degree of linkage
conservation with human chromosomal regions with disease
genes, would be ideal for testing the SB system in this context.
The Chromosome 11 region between the Trp53 (69.3 Mb) and
Wnt3 (103.6 Mb) loci is very gene dense and is syntenous to a
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disease genes [9]. The Inv(11)8Brd
Trp53–Wnt3 strain of mice
harbors an engineered inversion, generated using embryonic
stem cell technology, between these two genes [10]. Kile et al.
used the chemical agent N-ethyl-N-nitrosourea (ENU) to
mutagenize this Chromosome 11 region of the mouse
genome, taking advantage of this engineered chromosome
as a ‘‘balancer’’ chromosome to facilitate identiﬁcation of 88
recessive mutations, including lethals, between the Trp53 and
Wnt3 loci [11]. Although this approach has uncovered
interesting biology in this region of the genome [11,12],
associating a single gene disruption with a phenotype has
been a challenge due to the lack of a molecular landmark for
identifying the ENU-induced mutation. The 88 reported
mutations, however, provide an opportunity to evaluate the
results of a saturation mutagenesis screen using transposons
in the same region of the genome and potentially to assign
speciﬁc genes to similar phenotypes, because the transposon
serves as a molecular tag for mutation.
Using a donor site of mutagenic transposon vectors on
mouse Chromosome 11, near the 90-Mb position, we tested
the SB transposon system in a three-generation, forward-
genetic, regional mutagenesis screen for recessive-lethal and
viable phenotypes. Here we report the recovery of visible and
behavioral mutants, a high rate of recessive lethal pheno-
types, and the identiﬁcation of alternative mechanisms of
transposition-mediated mutation. We also compare our
experiences to the ENU-based mutagenesis of the same
region [11,12] and the aforementioned SB transposon-
induced regional mutagenesis of mouse Chromosome 12 [5].
Results
Generation of Mice for a Forward-Genetic Screen
The protocol for SB-mediated germline mutagenesis has
been described by multiple groups [2,3,13]. Brieﬂy, two mouse
strains, one transgenic for a mutagenic SB transposon vector
(mutator), and the other strain transgenic for a SB trans-
posase expression construct (jumpstarter), are bred together
to generate doubly transgenic ‘‘seed’’ mice. The transposase
mobilizes transposons in developing gametes of seed mice,
and the events are recovered in an outcross generation.
The T2/GT3/tTA ‘‘gene-trap tTA’’ vector (Figure 1A) and
generation of transgenic mice is described elsewhere [8].
Founder line 6660 was previously mapped to chromosome 11,
band 11C, by ﬂuorescence in situ hybridization (FISH), and
harbors a concatemer of approximately 30 copies of the
transposon vector [8]. We renamed this line the ‘‘GT3A’’ line
and used two different strains of transgenic mice to mobilize
these transposons from their Chromosome-11 donor site in
the germline of mice. Using the CAGGS-SB10 strain [2] as a
source of transposase, we can achieve germline mobilization
rates of nearly three events per gamete [8], whereas we report
here that the RosaSB11 strain [7] can mobilize the T2/GT3/
tTA transposon at a rate of one insert per gamete
(unpublished data). We also veriﬁed by progeny testing and
FISH that phenotypically normal homozygous GT3A off-
spring could result from an intercross of hemizygous carriers
(unpublished data).
Design of a Screen to Mutagenize Mouse Chromosome 11
Transposase-negative offspring of seed mice that inherited
the transposon donor site by Southern blot (Figure 1B) were
designated with a pedigree letter and entered as ﬁrst-
generation animals into a three-generation breeding scheme
(Figure 1C). We took advantage of the Inv(11)8Brd
Trp53–Wnt3
strain of mice to preferentially homozygose local transposon-
induced mutations in Chromosome 11 between Trp53 and
Wnt3. Carriers of the balancer chromosome are identiﬁed by
expression of an Agouti transgene incorporated into one
breakpoint of the engineered inversion [11]. Additionally,
animals inheriting two copies of the balancer chromosome
die in utero because one inversion breakpoint is in the
essential Wnt3 gene [11].
The results of the ENU screen [11,12] gave insight into the
phenotypes we might expect to recover, and importantly,
might be rare to discover in a screen. Recessive lethal (63%),
neurological (11%), skeletal (6%), and growth/size defects
(6%) made up the majority of recovered phenotypes in that
study [11]. Anticipating recovery of a similar range of
phenotypes, a comparable phenotype screen was designed
to recover mutations resulting in growth/size, neuromuscular,
or behavioral phenotypes and to identify craniofacial or limb
defects (see Materials and Methods). Two control pedigrees,
generated in the absence of the transposase strain, were
randomly introduced into the screen and were found to be
phenotypically normal. Thirty-eight pedigrees were screened
using this strategy, resulting in one visible, one behavioral,
and 21 recessive, prenatal lethal phenotypes (Table 1).
Local Transposition and Gene Mutation on Mouse
Chromosome 11
Transposon insertions in the genomes of mutant mice were
characterized using previously described methods [6] to
measure progress on saturating this gene-dense region with
mutations and to catalog any gene disruptions. The NCBI
m34 build (May 2005 freeze) was used to identify the genomic
position of 175 unique T2/GT3/tTA insertion sites using the
BLAST function of the ENSEMBL genome browser http://
www.ensembl.org/Mus_musculus/blastview. A full descrip-
tion of the genomic position for the local and genome-wide
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Synopsis
Perhaps the greatest challenge for biomedical research in the post-
genomics era will be to assign functions to the human set of
;25,000 genes. The classical method for discovering the gene
function is mutation. Thus, technologies that can mutate genes in
mammalian genetic models like the mouse are under development
in hopes of creating an efficient method to complete this task. One
such technology, the Sleeping Beauty (SB) transposon system, was
developed for this purpose in 2001. This mobile DNA element is
highly active in transgenic mice and has been shown to disrupt
mouse genes efficiently. Geurts et al. describe a novel attempt to
use the SB transposon in a forward-genetic screen using an
insertional mutagen, the first attempt of its kind. They discovered
that the process of transposon mobilization in mouse chromosomes
can lead to dramatic effects on local genomic sequences. Indeed,
transposons like SB can cause genomic rearrangements including
deletions, inversions and translocations, involving tens of thousands
to tens of millions of base pairs. This discovery has important
implications for using transposable elements for mouse germline
mutagenesis and, at the same time, may provide a model for
studying genomic rearrangements that have helped shape verte-
brate genomes during evolution.insertions can be found in Table S1. As predicted, 104
insertions (59%) were localized to mouse Chromosome 11
and, of those, 75 mapped to the balanced region between
Trp53 and Wnt3 (Figure 2). In total, 67% (50/75) of insertions
within the balanced region were inserted into 38 different
known or predicted genes (Table S1).
Dominant Polysyndactyly and Recessive Hyperactivity
Phenotypes of Mutant Pedigrees
Dominant polysyndactyly is evident in carriers of the
mutagenized Chromosome 11 in pedigree BM (Figure 3A).
These mice demonstrate duplication and often fusion of the
anterior digit on the fore and hind limbs. The open ﬁeld test,
performed in the SHIRPA arena (see Materials and Methods),
identiﬁed a recessive hyperactivity phenotype as homozygous
BG animals traveled through more squares when compared
to their control siblings (Figure 3B).
Candidate gene insertions were identiﬁed in the mutagen-
ized Chromosome 11 of pedigrees BM and BG. Heterozygous
pedigree BM mice harbor an insertion (03A-0204, Table S1)
in a pioneer gene (UniProt/TrEMBL ID Q5SRA9). This gene is
highly conserved throughout all major animal phyla, yet no
clues as to its function have been reported in other model
organisms. Homozygous pedigree BG animals display the
hyperactive phenotype and harbor an insertion (03A-0355,
Table S1) in a member of a family of genes known to be
expressed in the nervous system and that have been
associated with neurological disorders. We are currently
attempting to correlate these candidate single-gene disrup-
tions on Chromosome 11 with phenotypes. However, sub-
sequent analysis of the recessive prenatal lethal phenotypes
led us to discover that other types of mutations were present
on Chromosome 11 in these and other pedigrees, as is
described below. Thus, it is possible that transposon
insertions are not responsible for these viable phenotypes.
Recessive Lethality as a Result of Transposon Mutagenesis
of Chromosome 11
As mentioned above, 21 of the 38 pedigrees demonstrated
recessive lethality, all of which were prenatal lethal (Table 1).
While we anticipated a high rate of recessive lethal
phenotypes, this result was in stark contrast to the ENU
study where out of 55 (recently updated to 59 [12]) recessive
lethal phenotypes isolated, only 30 were characterized as
prenatal [11]. Based on the initially reported 55 of 88
balanced ENU-induced mutations resulting in lethal pheno-
types [11], this region of the genome may harbor a higher
than average density of essential mouse genes. SB trans-
position-induced lethal pedigrees harbored nearly twice as
many potential gene disruptions per pedigree on average
than non-lethal pedigrees (1.7 vs. 0.9) (Table 1). One
possibility is that the germline mobilization rate is sufﬁciently
high such that the screen would identify lethal mutations at
this rate. We addressed this hypothesis by both analyzing
candidate gene disruptions and complementation testing
between lethal pedigrees.
Candidate gene insertions in lethal pedigrees were exam-
ined for their association with lethal phenotypes. Carriers
were repeatedly outcrossed until recombinants were ob-
tained separating pedigree M insertion 03A-0033, in the
mouse carbonic anhydrase 10 gene (Car10), and pedigree V
insertion 03A-0063, in the mouse myosin heavy chain 2 gene
(Myh2) (Table S1), from all other insertions and the donor site
(unpublished data). Carriers of the isolated insertions were
intercrossed to discover any associated recessive phenotypes.
Homozygous carriers of either insertion were fertile, healthy
mice, and displayed no visible or behavioral abnormalities in
our assays, showing that the lethality in these pedigrees was
not due to transposon insertions in these genes. These gene
Figure 1. Design of a Forward-Genetic Screen
(A) The T2/GT3/tTA gene-trap tTA transposon was designed with splice
acceptors (SA) in both orientations and the bidirectional SV40
polyadenylation signal (pA) to truncate expression of an endogenous
gene after insertion into an intron. LoxP recombination sites (gray
arrowheads) flank the mutagenic core of the transposon to potentially
rescue a transposon-induced mutation.
(B) Southern blot and PCR analysis (þ/–, top) was used to identify G1
animals that inherited the concatemer, but not the transposase
transgene (asterisk).
(C) Insertions (red rectangle) genetically linked to the concatemer
donor site (black rectangles) on Chromosome 11 (—) are
homozygosed in a three-generation breeding scheme using the
Inv(11)8Brd
Trp53–Wnt3 strain balancer chromosome ($)w i t hi t s
engineered Wnt3 mutation and visible Agouti marker conferring a
yellowish color to the ears and tail. G1 animals were crossed to
mice that carry a balanced Rex (curly coat) mutation (gray outline).
Animals inheriting two copies of the balancer die in utero.
DOI: 10.1371/journal.pgen.0020156.g001
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their effect on gene expression. Figure 4A shows the RT-PCR
analysis on tissues from wild type, carrier, and homozygous
animals for each insertion. Insertion 03A-0033 does not
appear to alter expression of Car10, although insertion 03A-
0063 ablates expression of Myh2 at the level of transcription.
We have previously published that the carp ß-actin splice
acceptor in the T2/GT3/tTA does not always function to
intercept splicing as designed [8] and is apparently defective
in disrupting Car10 expression here. The reverse orientation
splice acceptor (Figure 1A), derived from the mouse
hypoxanthine phosphoribosyltransferase gene [8], however,
is effective in the case of the Myh2 insertion.
Myh2 encodes the myosin heavy chain IIa peptide (MyHC-
IIa) and is one of three adult fast skeletal muscle myosin genes
clustered on mouse Chromosome 11 [14]. Immunohistochem-
ical staining of the soleus muscle from homozygous carriers
of insertion 03A-0063 demonstrate lack of MyHC-IIa in
muscle ﬁbers, compared to carrier and wild-type sibling
controls (Figure 4B). Null mutations in the other two
Chromosome-11 fast muscle myosins, IIb [15], and IId [16],
are also viable, but they demonstrate severe muscle pathol-
ogy. It was demonstrated in those studies that neighboring
Chromosome-11 MyHC genes can compensate for the loss of
expression of one MyHC in mutant mice, though they are not
functionally redundant [14]. Figure 4B presents evidence that
MyHC genes on other mouse chromosomes can compensate
as well since type I MyHC, encoded by the Myh7 gene on
mouse Chromosome 14, is upregulated in IIa mutant muscle.
Complementation Testcrosses Reveal Major
Complementation Groups
To assess whether any of the lethal pedigrees were allelic,
complementation testcrosses using G2 animals were per-
formed. ENU mutagenesis in the same region of the genome
revealed 23 complementation groups among 24 lethal
pedigree testcrosses [11]. In contrast, most of the pedigrees
generated by transposon mutagenesis fell into one of two
major complementation groups (designated I and II, Figure
5), suggesting that most of our lethal pedigrees were the result
of one of two mutations occurring repeatedly in our screen.
Interestingly, pedigrees Z and BL failed to complement all
pedigrees except AG, AX, and BC, which complemented all
pedigrees tested with the single exception being that AX did
not complement pedigree AS. Pedigrees Z and BL, therefore,
have mutations that overlap with both major complementa-
tion groups, while AS likely has more than one lethal
mutation since it fails to complement group I pedigrees
and, separately, pedigree AX. Pedigrees AG and BC have
unique lethality-inducing mutations. Additionally, pedigrees
CQ and CD, generated with the RosaSB11 source of trans-
posase, fell into groups I and II, respectively, suggesting that
neither reducing the transposition rate, nor using the
catalytically enhanced SB11 transposase [17], can eliminate
the incidence of the mutations arising in the two major
complementation groups. Having cloned many insertions
from these mice, the prevalence of two major complementa-
tion groups could not be explained by the repeated
disruption of the same essential mouse genes (Table S1).
Thus, we investigated whether other types of mutations might
occur near the donor site to explain these observations.
Microdeletions, Inversions, and Chromosomal
Translocations as a Result of Transposition
To determine whether local genomic rearrangements are
present near the donor site of mutant chromosomes, FISH
was used to probe control and mutant pedigree chromo-
somes. Several bacterial artiﬁcial chromosome (BAC) clones
were obtained spanning a 1-Mb region from 89.6–90.6 Mb
Figure 2. Distribution of Chromosome 11 Insertions
The insertions over the entire Chromosome 11 and the gene-dense,
balanced region between Trp53 and Wnt3 are shown as a histogram over
the ENSEMBL ContigView (http://feb2006.archive.ensembl.org/
Mus_musculus/contigview?region¼11&vc_start¼69.3M&vc_end¼103.
6M&h¼11). The number of insertions over the whole chromosome is
shown in 1-Mbp bins, while the balanced region is shown in 100-kb bins.
DOI: 10.1371/journal.pgen.0020156.g002
Table 1. Pedigree Phenotype and Cummulative Insertion Data
Strain Phenotype Number Pedigree Designation Chromosome-11
Insertions
a
In Genes
b
GT3A; CAGGS-SB10 Recessive prenatal lethal 19 M, Q, V, W, Z, AG, AL, AO, AP, AS, AU, AX, AY, BA, BB, BC, BH, BL, BM 50 32
Behavioral 1 BG 4 3
Skeletal 1 BM
c 21
No phenotype 9 T, AD, AM, AQ, AT, AV, AZ, BI, BK 19 10
GT3A; RosaSB11 Recessive prenatal lethal 2 CD, CQ 4 3
No phenotype 6 CE, CF, CG, CH, CJ, CL 1 1
aNumber of independent insertions identified.
bIncludes insertions in known or predicted genes and mapped expressed sequence tags.
cThis pedigree also displays recessive early embryonic lethality.
DOI: 10.1371/journal.pgen.0020156.t001
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Genomic Rearrangement by Transposition(according to ENSEMBL m34 build, May 17, 2005 freeze) and
ﬂanking the presumptive donor site based on insertion data
(Figure 2). Each of ﬁve BAC clones (Figure 6A), detected with
rhodamine (red), was co-hybridized with a ﬂuorescein-
detected (green) transposon probe to metaphase chromo-
some preparations. Red signals for each probe were present
near the green donor site of GT3A control mice, suggesting
that none of the regions covered by the probes were deleted
in the initial transgenesis (unpublished data).
Hybridization of pedigree W demonstrated a loss of signal
from BAC probes 424I8 and 107H16 (Figure 6B, white arrows)
when compared to the normal copy of Chromosome 11,
suggesting a loss of more than 300 kb of genetic material
adjacent to the donor site. Pedigree AG was previously
conﬁrmed to be a lethal pedigree because homozygous
carriers of an insertion near the concatemer donor site
(03A-0071, Table S1) cannot be generated (p ,0.01 by v
2
analysis, unpublished data). BAC probing revealed a sizeable
insertion involving a portion of the concatemer (Figure 6C,
white arrowheads), and at least 400 kb of distal Chromosome
11 sequence overlapping probes 403C3 and 107H16 (yellow
arrows), into distal Chromosome 5 as determined by spectral
karyotyping (unpublished data). Thus, these mice have two
normal copies of Chromosome 11, which explains why
pedigree AG complements all other pedigrees (Figure 5).
This is the second example of insertion of the GT3A
concatemer into another chromosome, as we previously
reported the insertion of a large portion of the concatemer
into Chromosome 4 and subsequent local transposition from
the translocated donor site to a nearby gene [8]. A third
mutant pedigree revealed a large inversion covering tens of
millions of base pairs. Multiple green transposon signals can
be observed in pedigree BC, suggesting multiple copies of the
gene-trap tTA vector were involved in complex rearrange-
ments since a single copy of the transposon could not be
detected by this probe (unpublished data). One rearrange-
ment situated the red signals for probes 297L3 and 367E18 to
a more proximal position along Chromosome 11 when
compared to the normal copy (Figure 6D, ﬁrst two panels).
Based on the physical distance of the probes, this inversion
likely encompasses more than 50 million base pairs.
The representational oligonucleotide micro array (ROMA)
technique was developed to identify genome-wide copy
number variation in tumor DNA [18]. ROMA analysis of
mutant pedigree genomic DNA veriﬁed that, although the
rest of the genome was unaffected (unpublished data), a
reduction in copy number of a portion of mouse Chromo-
some 11 was seen in pedigree W and an ampliﬁcation of
Chromosome-11 sequences was seen in pedigree AG (Figure
7A). Based on the UCSC mm5 build (May 2004 freeze),
pedigree W deletion extends from approximately 89.7–90.1
Mb, a loss of ;400 kb of sequence, while the ampliﬁcation
(due to insertion of sequences from Chromosome 11, Figure
6C) in pedigree AG was a roughly 1.9-Mbp region from
;90.3–92.2 Mb. This insertion is detected as ampliﬁcation by
ROMA because the region of Chromosome 11 that would
have shown a deletion was bred away. Thus, pedigree AG
animals now have two normal copies of Chromosome 11 in
addition to the inserted 1.9-Mbp region into Chromosome 5.
Figure 7B summarizes ROMA and FISH data collected for
Chromosome 11 rearrangements from various pedigrees. We
propose that the two major complementation groups (Figure
5) can be explained by overlapping deletions that occurred
during transposition. Complementation group I, represented
by pedigrees AL, BB, AS, V, BM, and CQ, carry overlapping
deletions detectable by ROMA (blue bars) or FISH (black
bars) in a region of Chromosome 11 immediately distal to the
predicted concatemer donor site (Figure 7B). This region
harbors the syntaxin binding protein 4 gene, and mouse
homologs of a yeast cytochrome C oxidase assembly protein,
and of the chicken target of myb1-like 1 (Tom1l1) genes (blue
box, Figure 7B). Even though it is a member of complemen-
tation group I, pedigree AO did not harbor a deletion
detectable by the ROMA technique. This pedigree, rather,
harbors multiple transposon insertions, one within the non-
complementation region just deﬁned by the pedigrees above,
situated in Tom1l1 (insertion 03A-0297, Table S1), and may
indicate that Tom1l1 is essential.
In contrast to those distal mutations caused by trans-
position, pedigrees W, BH, AP, and AY, members of
complementation group II, have overlapping deletions which
are proximal to the predicted donor site. This region
contains the monocyte to macrophage differentiation-asso-
ciated and hepatic leukemia factor genes (orange box, Figure
7B). ROMA analysis of pedigree AP also identiﬁed a tandem
Figure 3. Visible and Behavioral Phenotypes as a Result of Transposon
Mutation
(A) Dominant polydactyly (extra digits) or polysyndactyly (extra, fused
digits) is evident in the fore (top) and hind limbs (bottom) of animals in
pedigree BM.
(B) A recessive hyperactive phenotype is measured by the number of
squares visited in the SHIRPA arena (see Materials and Methods) in
homozygous animals in the viable pedigree BG (p ¼ 0.0113 by unpaired
t-test).
DOI: 10.1371/journal.pgen.0020156.g003
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Genomic Rearrangement by Transpositionduplication of Chromosome-11 sequences distal to the donor
site (Figure 7B).
The ;4.3-Mbp deletion in pedigree Z, detected by ROMA,
explains why this pedigree fails to complement either group I
or group II pedigrees, because this larger deletion would
cover both of the above regions. Additionally, the non-lethal
pedigree BG contains two separate deletions not immediately
adjacent to the donor site, minimally deﬁned by FISH,
suggesting that these regions do not harbor essential
sequences. Two cases of insertion translocations have been
identiﬁed as demonstrated in pedigree AG (Figure 6C) and a
previously described translocation involving just the trans-
poson concatemer [8]. Finally, pedigree BC harbors both
inversions and deletions, deﬁned by FISH (Figure 6D) and
ROMA (Figure 7B). In summary, out of nine examined cases
of transposon mobilization on Chromosome 11, every
pedigree demonstrated some form of genomic rearrange-
ment, spanning hundreds of thousands to tens of millions of
base pairs.
Genome Rearrangements in Somatic Cells of a GT3A;
RosaSB11 Mouse
To determine whether genomic rearrangements similar to
those inherited in our germline screen could be detected in
somatic cells, we probed cell preparations from a GT3A;
RosaSB11 mouse and a control GT3A mouse by FISH using
the same BAC probes as above. Screening interphase and
metaphase chromosomes revealed a 40% frequency of signal
loss from BAC probe 424I8 (Figure 8), suggesting this region
is frequently deleted or a clone of deleted cells existed in the
spleen. A background of approximately 7–10% probe non-
detection existed when probing control GT3A cells with any
BAC or transposon probe due to technical artifacts associ-
ated with the FISH method. Loss of signal 107H16 could be
veriﬁed at a low frequency because the red 107H16 probe
signal was not adjacent to the green transposon signal in
some interphase cells (Figure 8). One rare cell also demon-
strated translocation and possible ampliﬁcation of signal
from probe 403C3 (Figure 8). These data, summarized in
Table S2, suggest that chromosomal rearrangements and
deletions can be readily identiﬁed in somatic tissues when
transposons and transposase are present in the same cell.
Discussion
We have investigated the utility of the SB transposon
system as a forward-genetic tool in the mouse germline to
recover a range of lethal and viable phenotypes. In a limited
number of pedigrees, we recovered one dominant limb and
one recessive behavioral phenotype. Unexpectedly, however,
genomic rearrangements including deletions and inversions
near the transposon donor site, as well as insertion of the
donor site plus nearby Chromosome-11 sequences into other
chromosomes, caused a high frequency of early embryonic
phenotypes in our screen. We hypothesize that the donor site
of transposons is situated between these two sets of deletions
(Figure 7B, blue and orange boxes), and that transposition
resulted in deletions that were proximal or distal to the
donor site. We further hypothesize that sequences contained
Figure 5. Complementation Testcrosses
For each testcross, heterozygous animals from independent lethal
pedigrees (see Table 1) were intercrossed to obtain offspring that
inherited both copies of their respective mutagenized chromosomes as
detected by PCR genotyping or balancer screening (see Figure 1B).
Noncomplementation ( ) and complementation (þ) divided the lethal
pedigrees into at least six complementation groups, with two major
groups labeled I and II. Pedigrees highlighted in pink complemented
every other pedigree tested except one case, where AX failed to
complement AS. Pedigrees in blue failed to complement pedigrees other
than AG, AX, and BC (purple).
DOI: 10.1371/journal.pgen.0020156.g005
Figure 4. Molecular Analysis of T2/GT3/tTA Gene Disruptions
(A) RT-PCR analysis of wild-type ( / ), hemizygous ( /þ), and homo-
zygous (þ/þ) carriers of insertions 03A-0033 and 03A-0063 are compared.
Primers to the housekeeping Gapdh gene were used as an internal
control for sample quality.
(B) Immunohistochemical staining of wild-type (wt), carrier, and null
soleus muscles for MyHC type IIa (top) and type I (bottom). Samples were
co-stained with Anti-Laminin to outline individual fibers.
DOI: 10.1371/journal.pgen.0020156.g004
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Genomic Rearrangement by Transpositionwithin these deleted regions are essential, and thus result in
the recessive lethal phenotypes we observed. We also
observed similar de novo rearrangements in somatic cells.
These genetic changes may not have been previously
recognized because earlier studies involved sequence- or
expression-driven approaches. Through a forward-genetic
approach, we identiﬁed a high frequency of recessive lethal
mutations, and then by complementation testing and
molecular analysis, determined the nature of the lesions.
Small- and large-scale local genome rearrangements
including insertions, deﬁciencies, duplications, inversions,
and translocations are a common result of Ac/Ds [19–21],
Tam3 [22], Tc1 [23], P [24,25], and bacterial [26] element
transpositions. Although we have not speculated on the
mechanisms by which SB transposons cause rearrangements,
the mechanisms for those elements, representing three major
families of eukaryotic cut-and-paste transposons, are well-
characterized in those reports. Genomic rearrangements
caused by alternative transposition of P [25] and Ac/Ds [19–
21] elements are particularly well understood and the
involvement of the latter in altering the structure of Maize
genes is now known [27]. The SB-induced genomic rearrange-
ments reported here could be caused by alternative mecha-
nisms of transposition, or due to chromosome instability
caused by double-strand breakage during excision and
integration. In either case, these events may have been
exacerbated by the fact that the GT3A donor site consists of
many identical copies of the transposon elements and the
high mobilization rate in the GT3A strain.
This discovery has implications for using SB and possibly
other transposable elements as mutagenic tools in the mouse
germline and soma. A recent study took advantage of the
local hopping phenomenon of SB transposons to demon-
strate regional saturation mutagenesis [5]. Employing a
Figure 6. Molecular Evidence of Chromosomal Rearrangements after Transposition
(A) Five BAC probes (red bars) were designed to the Chromosome 11 region from approximately 89.6–90.6 Mb (ENSEMBL m34 build, May 17, 2005
freeze). The transposon donor site (green) is presumed to be within the bracketed area based on the accumulation of insertions in this region. Single
copies of the transposon were not detectable in this assay. Representative FISH hybridizations to metaphase preparations are shown.
(B) Evidence for deletion of BAC signals 424I8 and 107H16 in pedigree W (white arrows).
(C) Translocation of transposons (white arrowheads) along with distal Chromosome 11 sequence (yellow arrows) in pedigree AG.
(D) Evidence for inversion of a large region of Chromosome 11 is detected by BAC probes 367E18 and 297L3 (red arrows) in pedigree BC, likely involving
multiple copies of the transposon.
DOI: 10.1371/journal.pgen.0020156.g006
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Genomic Rearrangement by TranspositionpolyA-trap design, insertions were cloned from sperm and
identiﬁed in every gene over a 4-Mb interval. The data
presented here suggest other genetically linked lesions often
accompany insertions in local genes. Indeed, single gene
insertions were identiﬁed in the cases of the dominant
polysyndactyly and recessive hyperactivity, seen in pedigrees
BM and BG, respectively. Further analysis, however, led us to
discover genomic deletions within the mutagenized Chromo-
some 11 in each of these pedigrees that are also genetically
linked to these phenotypes. Pedigree BM, along with the
polysyndactyly phenotype, is a member of complementation
group 1 (Table 1, Figure 7B) and harbors a deletion distal to
the concatemer donor site. The hyperactive pedigree BG
contains two separate deletions (Figure 7B) in addition to
single copy insertions. Since these genomic rearrangements
and transposon insertions are genetically linked to the
phenotypes we observed, we cannot rule out that the
deletions are not causative. As is always the case, it will be
crucial to prove that any transposon insertion causes the
observed phenotype by remobilizing it from within the gene
by re-exposure to transposase, by removing the mutagenic
elements of the vector, or transgene rescue. We have
previously reported that the germline mobilization rate of
single-copy elements is only about 1%, and thus loxP
recombination sites were engineered into the T2/GT3/tTA
transposon (Figure 1A), ﬂanking the mutagenic core of the
transposon, to potentially rescue expression of a gene [8].
Somatic transposition of oncogenic SB transposons is a
powerful method for studying the cancer genome of tumors
previously inaccessible to retroviral insertional mutagens
[6,7]. We have aged several GT3A; SB11 mice and have seen
no statistically signiﬁcant increase in mortality compared to
controls. It will be important, however, to closely examine
whether continuous transposon mobilization leads to ge-
nomic rearrangements that can contribute to cancer develop-
ment in these models. Additionally, although Sleeping Beauty
was the ﬁrst vertebrate transposon system shown to be active
in the germline and somatic cells of mice in vivo, the ﬂy
transposon Minos [28] and the lepidopteran piggyBac element
[29] were more recently developed for these purposes. Minos,
like SB, belongs to the Tc1/mariner superfamily of transposons
and, although piggyBac is in a family of its own, due to their
cut-and-paste mechanism of mobilization and local hopping
activities, they likely have the potential to cause similar
genomic rearrangements as we have reported on here. While
analyzing the results of mobilizing these vectors, it will be
important to include methods to detect these mutations.
Finally, we propose that the genomic rearrangements
caused by mobilization of SB transposons may serve as a
model for the genomic rearrangements that have occurred
during the evolution of vertebrate genomes. Major rearrange-
ments that lead to the observed conserved blocks of synteny
between mouse and human chromosomes are consistent with
random chromosomal breakage [30]. Mainstream hypotheses,
however, correlate smaller scale rearrangements, including
insertion, deletion, inversion, and duplications within chro-
mosomes, with the ampliﬁcation and activities of trans-
posable elements [31–33] though most attention has been
given to copy-and-paste elements. To our knowledge, this is
the ﬁrst report of local genomic rearrangements caused by a
cut-and-paste transposon in a vertebrate. As far as is known,
cut-and-paste transposons have been inactive in mammalian
genomes for tens of millions of years [34,35]. Nevertheless,
cut-and-paste elements do lead to genomic rearrangement in
nature, as endemic inversions in isolated populations of
Drosophila have been attributed to hobo-element cut-and-paste
activity [36]. We have shown here that the high frequency of
transposition of the teleost ﬁsh-derived SB element [37] in
transgenic mice can cause similar rearrangements at high
frequency. Though the synthetic SB element is likely to be
Figure 7. Defined Genomic Rearrangements Caused by Transposition
(A) Moving average plots of ROMA data of deletion in pedigree W and amplification (due to insertion) in pedigree AG.
(B) Summary of rearrangements as determined by FISH (black bars) or ROMA (blue bars). The green box represents the concatemer, though its position
relative to the deletions is speculative. ROMA detects loss (---) of chromosomal material, and defines the minimal overlapping regions for
complementation groups 1 (blue box) and 2 (orange box), as well as amplification (þþþ) of genomic sequences. Where the FISH method was used
(black bars) the true extent of each rearrangement could not be determined.
DOI: 10.1371/journal.pgen.0020156.g007
Figure 8. De Novo Rearrangements in Somatic Cells of a GT3A; RosaSB11
Mouse
Metaphase and interphase FISH images of normal (A, C, E) and abnormal
(B, D, F) splenic lymphocytes from a doubly transgenic mouse are shown
using the same probes as Figure 6. Evidence for deletion (white arrows)
and translocated Chromosome 11 sequences (yellow arrows) were
evident for these three probes. These data, including other probes, are
further summarized in Table S2.
DOI: 10.1371/journal.pgen.0020156.g008
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Genomic Rearrangement by Transpositionmuch more active than an endogenous cut-and-paste element
would have been millions of years ago, we postulate that
analogous rearrangements could contribute to the speciation
and evolution of vertebrates. Such mutations by a highly
active element would undoubtedly be deleterious to a host
species over several generations. It now seems plausible that
genomes evolved mechanisms to suppress cut-and-paste
elements to protect against these damaging rearrangements
rather than to prevent the accumulation of rare mutations
caused by single-copy insertions.
Materials and Methods
Phenotyping. At birth (P0), living and dead G3 pups were counted
and any gross abnormalities noted. Pups were tail clipped and
weighed at P14. G3 animals were weaned at 24 d, weighed and their
length measured before they were subjected to the wire hang and
negative geotaxis assays [38]. Animals were then placed in a SHIRPA
arena and activity measured for 30 s by counting the number of 113
11 cm squares visited, as deﬁned by having all four paws in the same
square at the same time. The gait and general behavior of the animals
were also monitored. Animals were given a visual inspection to detect
craniofacial or limb abnormalities.
RT-PCR and standard PCR genotyping. RNA was extracted and
RT-PCR performed as described [8]. Transposase transgene genotyp-
ing was done using standard techniques on tail biopsy DNA.
Individual insertion genotyping was done as previously described
using three-primer PCR [39]. Primer sequences for all PCR reactions
are available upon request.
Immunohistochemistry. Sections were cut from frozen muscle on
a Tissue Tek II microtome/cryostat (Miles Scientiﬁc, Naperville,
Illinois), ﬁxed, and stored at  20 8C until use. Slides were air dried
followed by incubation in permeabilizing/blocking solution (P/BS)
(0.12% BSA, 0.12% nonfat dry milk, 0.1% Triton X-100 in
phosphate-buffered saline [PBS]) plus 5% normal goat serum for
1 h at 4 8C and then rinsed three times in PBS. SC-71 (used as an
undiluted hybridoma supernatant) reacts with MyHC-IIa (Myh2),
NCL-MHCs (Novocastra Laboratories Newcastle-upon-Tyne, United
Kingdom, 1:50 dilution) reacts with MyHC-I (Myh7), and Anti-
Laminin (Sigma-Aldrich, St. Louis, Missouri, United States, 1:200
dilution) aided in muscle ﬁber identiﬁcation. Primary antibody
incubations were carried out at room temperature for 2 h, washed
twice with PBS and incubated twice for 5 min in P/BS. Secondary
antibody incubations were performed in P/BS at room temperature
for 2 h using Goat-anti-mouse FITC- or TR-conjugated IgG
(Jackson ImmunoResearch, West Grove, Pennsylvania, United
States, 1:100 dilution) for Anti-MyHC detection and FITC-con-
jugated goat-anti-rabbit (Jackson ImmunoResearch, 1:100 dilution)
for Anti-Laminin detection. Sections were washed 3 times with PBS,
incubated twice for 5 min in PBS, and mounted in glycerol-gelatin
(Sigma-Aldrich).
Fluorescence in situ hybridization. 129Sv library BAC clones
obtained complementary of The Wellcome Trust Sanger Institute
(Cambridge, United Kingdom) and the pT2/GT3/tTA transposon-
harboring plasmid [8], were labeled with biotin or digoxigenin,
respectively, by nick translation as we have previously described [1].
Probes were detected using rhodamine-conjugated strepavidin or
ﬂuorescein-conjugated anti-digoxigenin antibody, respectively (Rain-
bow Scientiﬁc, Windsor, Connecticut, United States), as also
described by Carlson et al [1].
Representational oligonucleotide micro array. High molecular
weight genomic DNA was isolated from mouse brain using the
Puregene Cell & Tissue kit from Gentra Systems (Minneapolis,
Minnesota, United States, #D-5500A). For pedigrees W and AG, wild-
type FVB/N strain DNA was used as a reference sample. BglII genomic
representations, and Cy3-dCTP (reference DNA) or Cy5-dCTP (DNA
of interest) incorporation, hybridization, and washing conditions
were done as described recently [18]. Hybridizations were carried out
on arrays bearing 85,000 oligonucleotides (NimbleGen, Systems,
Madison, Wisconsin, United States). Design of the mouse array probes
is described in Lakshmi et al. [40]. Slides were scanned with an Axon
GenePix 4000B scanner (Axon Instruments, Union City, California,
United States). Array data was imported into S-plus and was
normalized as in Lucito et al. [18]. The moving averages of raw Cy5/
Cy3 ratios are displayed in the ﬁgures. The genome position was
determined from the UCSC GoldenPath browser (http://genome.ucsc.
edu/cgi-bin/hgGateway?clade¼vertebrate&org¼Mouse&db¼mm5)
(May 2004 Assembly).
Supporting Information
Table S1. Positions of T2/GT3/tTA Insertions into Mouse Chromo-
somes
Linker-mediated PCR was used to determine the positions of 175
gene-trap tTA insertions after mobilization from the GT3A Chro-
mosome-11 donor site. Sorted by chromosome and position, the
insertions in the balanced region between Trp53 and Wnt3 are
highlighted in blue.
Found at DOI: 10.1371/journal.pgen.0020156.t001 (101 KB PDF).
Table S2. Summarized Somatic Fluorescence In Situ Hybridization
Data
FISH was performed on splenic lymphocytes of a GT3A; RosaSB11
mouse. Metaphase and interphase cells were screened for chromo-
some abnormalities using the same probes as shown in Figure 6. The
table summarizes the percentages of normal and abnormal cells
detected for each probe.
Found at DOI: 10.1371/journal.pgen.0020156.t002 (21 KB XLS).
Accession Numbers
Mouse Genome Informatics (http://www.informatics.jax.org) accession
numbers for genes mentioned in the text include Car10
(MGI:2144598), Myh2 (MGI:1339710), syntaxin binding protein 4
gene (MGI:1342296), mouse homologs of a yeast cytochrome C
oxidase assembly protein (MGI:1917052), Tom1l1 (MGI:1919193),
monocyte to macrophage differentiation-associated gene
(MGI:1914718), and hepatic leukemia factor (MGI:96108). The RefSeq
(http://www.ncbi.nlm.nih.gov/RefSeq) peptide accession number for
MyHC-IIa is NP_001034634. Additional accession number informa-
tion for potential gene disruptions may be found in Table S1.
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